- Home
- OGI vs SCPH Comparison
OGI vs SCPH Comparison
Compare OGI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- SCPH
- Stock Information
- Founded
- OGI 2013
- SCPH 2013
- Country
- OGI Canada
- SCPH United States
- Employees
- OGI N/A
- SCPH N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- OGI Health Care
- SCPH Health Care
- Exchange
- OGI Nasdaq
- SCPH Nasdaq
- Market Cap
- OGI 176.7M
- SCPH 173.6M
- IPO Year
- OGI N/A
- SCPH 2017
- Fundamental
- Price
- OGI $1.36
- SCPH $3.81
- Analyst Decision
- OGI
- SCPH Strong Buy
- Analyst Count
- OGI 0
- SCPH 3
- Target Price
- OGI N/A
- SCPH $14.00
- AVG Volume (30 Days)
- OGI 563.8K
- SCPH 301.8K
- Earning Date
- OGI 08-12-2025
- SCPH 08-13-2025
- Dividend Yield
- OGI N/A
- SCPH N/A
- EPS Growth
- OGI N/A
- SCPH N/A
- EPS
- OGI 0.10
- SCPH N/A
- Revenue
- OGI $135,031,829.00
- SCPH $41,982,000.00
- Revenue This Year
- OGI $50.30
- SCPH $108.95
- Revenue Next Year
- OGI $16.01
- SCPH $73.83
- P/E Ratio
- OGI $13.24
- SCPH N/A
- Revenue Growth
- OGI 20.49
- SCPH 138.10
- 52 Week Low
- OGI $0.85
- SCPH $1.94
- 52 Week High
- OGI $2.08
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- OGI 56.37
- SCPH 61.62
- Support Level
- OGI $1.25
- SCPH $3.84
- Resistance Level
- OGI $1.37
- SCPH $4.03
- Average True Range (ATR)
- OGI 0.06
- SCPH 0.18
- MACD
- OGI -0.01
- SCPH -0.05
- Stochastic Oscillator
- OGI 58.82
- SCPH 40.58
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.